SecBot SecBot

EDAP

EDAP TMS SA
Nasdaq· Electromedical & Electrotherapeutic Apparatus· CIK 0001041934 Healthcare & Medical Devices
Former ticker of EDAP TMS SA · FOCL stock page →
No price
Median target
$4.50
range $3.00–10.00
Short interest
56.1K
−1.7%
Days to cover
1.6
at average volume
Insider net
+$184.7K
4 buyers · 0 sellers · 12 mo
Filing reports
9
analyzed by SecBot
SecBot read MIXED 1 report · latest
Balance 0 bearish · 0 bullish · 1 mixed oldest → newest, height = score
Avg score

Price

Daily candles with volume.

Signal stack

Where each data set points today.

  • InsidersBULLISH

    4 insiders bought $184.7K at an average $4.62. No open-market sales.

  • EstimatesFALLING

    Current-quarter EPS estimate −$0.170 → −$0.205 over 90 days.

  • Short sellersSTEADY

    Short interest −1.7% to 56.1K shares. 1.6 days to cover.

The Street

Last action Jun 2026
Recent actions
DateFirmActionRating
Jun 2, 2026HC Wainwright & Co.
REITERATE
REITERATEBuy
Catalysts
Scheduled dates and disclosed events: earnings, FDA and trial readouts, halts, press releases. Colored dot = impact.
Recent
May 29, 2026
Press release
EDAP Announces Corporate Name Change to FocalTherics™ to Reflect Exclusive Focus on High-Growth Robotic Focal Therapy
, May 29, 2026 (GLOBE NEWSWIRE) -- EDAP Announces Corporate Name Change to FocalTherics ™ to Reflect Exclusive Focus on High-Growth Robotic Focal…
May 21, 2026
Press release
EDAP | Focal One to Present at Jefferies 2026 Global Healthcare Conference
, May 21, 2026 (GLOBE NEWSWIRE) -- EDAP | Focal One to Present at Jefferies 2026 Global Healthcare Conference
May 14, 2026
Contract
EDAP | Focal One and Telix Announce Collaboration Focused on Robotic HIFU and Theranostics in Prostate Cancer
, May 14, 2026 (GLOBE NEWSWIRE) -- AUSTIN, Texas, May 14, 2026, EDAP TMS S.A. (Nasdaq: EDAP) today announced that it has entered into a letter of…
May 13, 2026
Press release
EDAP | Focal One to Host Investor Day on June 1, 2026
, May 13, 2026 (GLOBE NEWSWIRE) -- EDAP | Focal One to Host Investor Day on June 1, 2026
May 7, 2026
Earnings
EDAP Reports Strong Financial Results with Record First Quarter HIFU Revenue
, May 07, 2026 (GLOBE NEWSWIRE) -- EDAP Reports Strong Financial Results with Record First Quarter HIFU Revenue

Insider ledger

Form 4
$184.7K
bought · 4 insiders
$0
sold · 0 insiders
DateInsiderTypeValue
Aug 14, 2026
Horn David R.
Director
Aug 14, 2026
BUY$47.5K
Aug 14, 2026
Annen Steven
SVP, Marketing & Product Mgmt.
Aug 14, 2026
BUY$23.8K
Aug 14, 2026
Mobeck Kenneth S.
Chief Financial Officer
Aug 14, 2026
BUY$23.8K
Aug 14, 2026
LEVINE JOSHUA
Director
Aug 14, 2026
BUY$47.5K
May 12, 2026
Mobeck Kenneth S.
Chief Financial Officer
May 12, 2026
AWARD120,000 sh
May 12, 2026
Mobeck Kenneth S.
Chief Financial Officer
May 12, 2026
AWARD144,141 sh
May 12, 2026
Shah Sanket
Gen Counsel & Corp Secretary
May 12, 2026
AWARD67,500 sh
May 12, 2026
Shah Sanket
Gen Counsel & Corp Secretary
May 12, 2026
AWARD75,000 sh

Earnings setup

Estimates
−$0.20
EPS estimate, this quarter
−21%
estimate change, 90 days
Current-quarter EPS estimate
PeriodEPS est.Range30D rev.Revenue
Current Q-$0.20-$0.24–-$0.17+6.8%$19.3M
Next FY-$0.59-$0.64–-$0.54+0.2%$79.8M
Current FY-$0.82-$0.86–-$0.78+1.2%$75.0M
Next Q-$0.23-$0.23–-$0.22-2.3%$16.5M

Short side

FINRA· May 29, 2026
56,059
shares short
-1.7%
vs prior settlement
1.6
days to cover
Recent activity
The latest filings, insider trades, analyst actions, press and options flow, newest first.
Aug 17, 2026 SEC
Four insiders, including CFO Kenneth Mobeck, SVP Steven Annen, and directors Joshua Levine and David Horn, purchased a…
CLUSTER · Impact 5/10
Aug 14, 2026 Insider
Horn David R. bought 10,000 shares
Director @ $4.75 ($47.5K)
Aug 14, 2026 Insider
Annen Steven bought 5,000 shares
SVP, Marketing & Product Mgmt. @ $4.75 ($23.8K)
Aug 14, 2026 Insider
Mobeck Kenneth S. bought 5,000 shares
Chief Financial Officer @ $4.75 ($23.8K)
May 29, 2026 SEC
EDAP TMS SA announced it will operate under the new corporate name 'FocalTherics' and change its Nasdaq ticker to…
8-K · Impact 4/10
May 29, 2026 Other
EDAP Announces Corporate Name Change to FocalTherics™ to Reflect Exclusive Focus on High-Growth Robotic Focal Therapy
, May 29, 2026 (GLOBE NEWSWIRE) -- EDAP Announces Corporate Name Change to FocalTherics ™ to Reflect
May 14, 2026 SEC
EDAP TMS SA filed its management report for the 2025 fiscal year ahead of the June 26, 2026 annual general meeting…
DEFA14A · Impact 6/10
May 14, 2026 Press
EDAP TMS announced a non-binding letter of intent with Telix Pharmaceuticals to explore joint clinical research and…
Impact 3/10

SecBot reports

9 filings · 3 press releases · 0 bullish · 1 bearish · 2 mixed · 6 neutral
All EDAP filing & press-release reports (12)